Oxford Asset Management LLP Sells 1,381 Shares of McKesson Co. (NYSE:MCK)

Oxford Asset Management LLP lessened its stake in McKesson Co. (NYSE:MCK - Free Report) by 73.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 500 shares of the company's stock after selling 1,381 shares during the quarter. Oxford Asset Management LLP's holdings in McKesson were worth $285,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in MCK. Millstone Evans Group LLC bought a new position in McKesson during the 4th quarter worth approximately $28,000. Synergy Asset Management LLC bought a new position in McKesson in the fourth quarter valued at approximately $32,000. Crews Bank & Trust bought a new stake in shares of McKesson in the fourth quarter worth $33,000. Atala Financial Inc bought a new stake in shares of McKesson in the fourth quarter worth $34,000. Finally, Graney & King LLC bought a new stake in shares of McKesson in the fourth quarter worth $38,000. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Trading Down 0.9 %

NYSE MCK traded down $6.25 during trading hours on Thursday, hitting $706.54. 957,600 shares of the company's stock were exchanged, compared to its average volume of 889,817. The stock has a 50-day simple moving average of $667.61 and a 200 day simple moving average of $610.61. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $728.32. The firm has a market cap of $88.55 billion, a price-to-earnings ratio of 32.35, a PEG ratio of 1.29 and a beta of 0.49.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, sell-side analysts anticipate that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.40%. McKesson's payout ratio is 13.00%.

Insider Activity at McKesson

In related news, CEO Brian S. Tyler sold 8,961 shares of McKesson stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares in the company, valued at approximately $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Leann B. Smith sold 188 shares of the business's stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the sale, the executive vice president now owns 1,051 shares in the company, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,110 shares of company stock valued at $10,855,706 over the last 90 days. Insiders own 0.11% of the company's stock.

Wall Street Analysts Forecast Growth

MCK has been the subject of several recent analyst reports. Evercore ISI raised their target price on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research note on Thursday, February 6th. Mizuho lifted their price target on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research report on Thursday, April 3rd. Wells Fargo & Company lifted their price objective on shares of McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a research note on Friday, March 14th. StockNews.com cut shares of McKesson from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Finally, Morgan Stanley boosted their target price on shares of McKesson from $642.00 to $745.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, McKesson presently has a consensus rating of "Moderate Buy" and an average target price of $681.00.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.